Investigating the Relationship Between Temporal Bone CT, Bone Density, and Hearing Loss in Otosclerosis Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
Sponsorİbrahim Emir Yeşil

About this trial

The goal of this observational case-control study is to evaluate the relationship between temporal bone computed tomography (CT) findings, bone mineral density (BMD), and audiological parameters in adults diagnosed with otosclerosis. The main questions it aims to answer are:

Is there a correlation between temporal bone CT density values and the severity of hearing loss in otosclerosis? Do bone mineral density and serum vitamin D levels differ between otosclerosis patients and individuals without otosclerosis? Researchers will compare patients diagnosed with otosclerosis to a control group without otosclerosis to determine if CT-based density variations are associated with disease severity and systemic bone metabolism markers.

Participants who have already had a temporal bone CT scan as part of their routine clinical evaluation will undergo:

Bone mineral density (BMD) assessment via dual-energy X-ray absorptiometry (DEXA) Serum vitamin D level measurement Audiological testing, including pure tone audiometry and speech discrimination tests This study aims to improve the diagnostic and prognostic understanding of otosclerosis by integrating imaging, metabolic, and audiological data.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults diagnosed with otosclerosis based on audiological and clinical assessment

Patients with available high-resolution CT scans and audiological data

Individuals who have undergone stapedectomy or stapedotomy surgery

Availability of bone mineral density and serum vitamin D data

Disqualifiers

History of primary metabolic bone diseases (osteoporosis, Paget's disease)

Use of medications affecting bone metabolism (bisphosphonates, corticosteroids)

History of chronic otitis media or prior ear surgeries

Patients who received head and neck radiotherapy

Trial population

The study population consists of adult patients evaluated at the Otorhinolaryngology Department of Hacettepe University for hearing-related concerns. Participants will be selected from individuals who have undergone audiological testing and temporal bone computed tomography (CT) imaging as part of their clinical assessment. The study includes two groups: Otosclerosis Patients (Study Group): Adults diagnosed with otosclerosis based on clinical, audiological, and radiological criteria. These patients have undergone or are scheduled for stapedectomy or stapedotomy surgery. Non-Otosclerosis Patients (Control Group): Individuals who have no clinical or audiological signs of otosclerosis but have undergone temporal bone CT for unrelated reasons, such as investigation of other otologic symptoms (e.g., vertigo, tinnitus, or trauma assessment). Participants will primarily be recruited from tertiary care settings within the hospital, ensuring access to specialized diagnostic and surgical inter

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

86 Participants
are grouped into 2 trial groups
Group A: Otosclerosis Group
Group B: Control Group

Trial outcomes

Primary outcomes

1

Temporal Bone CT Density Measurements

Measurement of bone density at key anatomical sites including the stapes footplate, oval window, and otic capsule, using Hounsfield Units (HU) from high-resolution temporal bone CT scans.

Time frame
Baseline (Preoperative assessment)
2

Pure Tone Audiometry (PTA) Thresholds

Hearing thresholds will be assessed using pure tone audiometry (PTA) across standard frequencies (500 Hz, 1000 Hz, 2000 Hz, 4000 Hz). The average PTA threshold (in dB HL) will be reported to evaluate the severity of hearing impairment.

Time frame
Baseline (Preoperative assessment)
3

Air-Bone Gap (ABG) Measurement

Air-bone gap (ABG) will be assessed at key frequencies (500 Hz, 1000 Hz, 2000 Hz, 4000 Hz) using pure tone audiometry. The mean ABG value (in dB HL) will be reported to evaluate the degree of conductive hearing loss.

Time frame
Baseline (Preoperative assessment)
4

Bone Mineral Density (BMD) Scores

Measurement of bone mineral density in lumbar spine and femoral neck using Dual-Energy X-ray Absorptiometry (DEXA) to explore systemic bone metabolism in otosclerosis patients.

Time frame
Baseline (Preoperative assessment)

Secondary outcomes

1

Correlation Between CT Density and Audiological Parameters

Analysis of the relationship between preoperative CT bone density values and audiometric findings to determine if CT markers predict hearing loss severity.

Time frame
Baseline (Preoperative assessment)
2

Association Between Otosclerosis Severity and BMD/Vitamin D Levels

Statistical analysis to determine whether systemic bone metabolism markers (BMD, serum vitamin D) correlate with otosclerosis severity, as assessed by CT and audiological tests.

Time frame
Baseline (Preoperative assessment)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

İbrahim Emir Yeşil

Lead sponsor

Hacettepe University

Sponsor institution